The purpose of this prospective study was to compare the subjective and objective outcome of laparoscopic (LNF) and conventional Nissen fundoplication (CNF) up to 5 years after surgery as obtained in a multicenter randomized controlled trial. Summary of Background Data: LNF is regarded as surgical treatment of first choice for refractory gastroesophageal reflux disease by many surgeons based on several short-and mid-term studies. The long-term efficacy of Nissen fundoplication, however, is still questioned as objective data gathered from prospective studies are lacking. Methods: From 1997 to 1999, 177 patients were randomized to undergo LNF or CNF. Five years after surgery, all patients were requested to fill in questionnaires and to undergo esophageal manometry and 24-hour pH-metry. Results: A total of 148 patients agreed to participate in the follow-up study: 79 patients after LNF and 69 after CNF. Of these, 97 patients (48 LNF, 49 CNF) consented to undergo esophageal manometry and 24-hour pH-metry. At 5 years follow-up, 20 patients had undergone reoperation: 12 after LNF (15%) and 8 after CNF (12%). There was no difference in subjective outcome, with overall satisfaction rates of 88% and 90%, respectively. Total esophageal acid exposure times (pH Ͻ 4) were 2.1% Ϯ 0.5% and 2.0% Ϯ 0.6%, respectively (P ϭ 0.21). Antisecretory medication was taken daily in 14% and 16%, respectively (P ϭ 0.29). There was no correlation between medication use and acid exposure and indices of symptomreflux association (symptom index and symptom association probability). No significant differences between subjective and objective results at 3 to 6 months and results obtained at 5 years after surgery were found.
L aparoscopic Nissen fundoplication (LNF) has become the leading surgical treatment of refractory gastroesophageal reflux disease (GERD). The reported subjective and objective short-and mid-term results are excellent and at least comparable to those of conventional Nissen fundoplication (CNF), while LNF is associated with reduced postoperative pain and shortened hospital stay and recovery period. [1] [2] [3] [4] The combination of sufficient effectiveness and reduced morbidity has resulted in an increase in referral of GERD patients for surgery.
Whereas the long-term subjective results of LNF on reflux symptoms and quality of life seem to be as good as those published after CNF, [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] ambiguity still exists about the durability of LNF since long-term objective data obtained in prospective studies are lacking. Furthermore, a gradual increase in recurrent need for proton pump inhibitors (PPIs), suggesting an increase in failure rate, still casts some doubt on the position of LNF as the definitive treatment of refractory GERD. [17] [18] [19] [20] In 1997, a multicenter randomized clinical trial was initiated in the Netherlands to compare the effectiveness of LNF with CNF in cohort of 200 patients. 2 The study was terminated after inclusion of 103 patients because of significantly more need for reintervention in the LNF group and its short-term results were published. 2 After 2 years of symptomatic follow-up patients, the difference between both groups was no longer significant. The purpose of the present study was to assess the long-term subjective and objective outcome of patients enrolled in the trial after a follow-up of more than 5 years after fundoplication to elucidate long-term objective outcome in a prospective study on both techniques.
METHODS

Study Design and Participants
From 1997 to 1999, 177 patients were included in a multicenter randomized controlled trial to undergo Nissen fundoplication for refractory GERD in one of the participating tertiary centers (n ϭ 98, LNF; n ϭ 79, CNF). After 3 months of follow-up in 103 patients, an interim analysis was performed and the study was terminated because of an overpresentation of complications necessitating surgical reintervention in the LNF group. In the time period needed for conducting and discussing the interim analysis, another 64 patients were randomized and operated. Six patients decided to withdraw from randomization after publication of the results of the interim analysis. Another 4 patients were excluded because they had never been operated or randomized.
All remaining 167 patients were prospectively followed for evaluation of the outcome of surgery. After 5 years, 8 patients were lost to follow-up, 4 had died (cause not related to their reflux disease), and 4 had emigrated during the follow-up period. Thus, a total of 151 patients were available for long-term follow-up. In Figure 1 , the CONSORT analysis is described in detail. 21 All patients were asked to complete a questionnaire on general quality of life, overall judgment, and quality of life by a direct rating scale and to undergo esophageal stationary manometry and 24-hour pH monitoring. Esophageal manometry and pH monitoring were conducted in the University Medical Center Utrecht, except for 11 patients who underwent these tests in one of the other participating university centers in the Netherlands.
Surgical Procedures
All primary operations were performed between January 1997 and August 1999. Both in the conventional and in the laparoscopic group, a floppy 360°Nissen fundoplication of 2.5 to 3 cm was constructed after full esophageal mobilization and posterior crural repair. Short gastric vessels were ligated and divided in all patients. Open surgery was performed through a standard upper midline incision.
Subjective Symptomatic Outcome
Long-term symptomatic outcome was determined using a general health questionnaire and the participant's global appraisal of general state of health was measured on a 10-cm visual analogue scale (VAS). The change in quality of life was compared with baseline, measured on a 4-point scale that ranges from "resolved" to "worsened." Furthermore, the self-rated change in reflux symptoms as compared with the preoperative state and satisfaction with overall outcome was determined.
Esophageal Manometry
Medication that could affect esophageal motility was stopped at least 48 hours in advance. Manometry was performed using a water-perfused system with a multiple-lumen catheter with an incorporated sleeve sensor (Dentsleeve Pty Ltd, Adelaide, Australia). A pneumohydraulic pump (Dentsleeve Pty Ltd) was used for perfusion with distilled water at a rate of 0.5 mL/min. The catheter was introduced transnasally into the stomach. Then, the catheter was retracted to determine the distal and proximal margin of the lower esophageal sphincter (LES) and to position the sleeve sensor at the level of the LES. Intraluminal esophageal pressures were recorded at 5, 10, and 15 cm above the upper margin of the LES. A side-hole 2 cm distal to the distal border of the sleeve sensor registered gastric pressure. The manometric response to 10 standardized wet swallows (5-mL water bolus) was recorded. The mean end-expiratory LES pressure and residual pressure of the LES during relaxation were determined over a period of 10 minutes. Herein, the end-expiratory gastric baseline 
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Long-term Results of Nissen Fundoplication pressure served as the zero reference point. The LES relaxation was judged to be normal if it exceeded 90% or if a residual pressure of less than 1.4 kPa (10.5 mm Hg) was measured. Mean amplitude and duration of the esophageal contractions in response to the wet swallows were determined for the proximal (15 cm above the LES), mid (10 cm), and distal esophagus (5 cm above LES).
24-Hour pH Monitoring
All studies were performed after suspending all medication including PPIs that could affect results for at least 3 days before pH-metry. PPIs were stopped 7 days before the 24-hour pH-metry. Intraluminal esophageal pH was measured using a pH glass electrode (model LOT440, Medical Instruments Corporation, Solothurn, Switzerland) connected to a digital data logger (MMS, Enschede, the Netherlands) using a sample frequency of 1 Hz. The catheter was introduced transnasally into the esophagus and was positioned 5 cm above the manometrically determined proximal margin of the LES. Patients were asked to register their reflux symptoms by pressing a button on the data logger as well by recording them in a diary. The phases of supine and upright position during the 24 hours were also recorded. Reflux parameters were calculated using a dedicated analysis program (Medical Measurements Systems BV, Enschede, the Netherlands).
The percentages of total time with esophageal pH Ͻ 4 and time in supine and upright position with pH Ͻ 4 were calculated. Next, the total number of symptom episodes, the symptom index (SI), expressing the percentage of symptom episodes related to reflux (pH Ͻ 4), as well as the symptomassociation probability (SAP), indicating the possible association between symptoms and reflux, were calculated. 22, 23 Symptoms were defined as reflux-related, if the SI was higher than 50%. The SAP was considered to be positive when it was higher than 95%. Pathologic reflux was defined as the percentage of time with pH below 4 for total time Ͼ5.78%, upright time Ͼ8.15%, and supine time Ͼ3.45%. 24
Statistical Analysis
All statistical analyses were performed using SPSS version 12.0.1 (SPSS Inc., Chicago, IL). Values are expressed as mean Ϯ SEM. The two-tailed Mann-Whitney U test was used to determine the significance of differences between nonparametric data and unpaired the Student t test was used to determine the significance of differences between data for which it was reasonable to assume a normal distribution. We compared groups with the 2 test for nominal variables. The Spearman coefficient was used to determine correlations between groups. Differences were considered statistically significant with a P value less than 0.05.
RESULTS
Overall Responses and Completeness of Follow-up
Three patients refused both subjective and objective follow-up. A total of 148 patients consented with long-term subjective follow-up ( Fig. 1) . Mean time to follow-up was 65.7 (1.8) months after LNF and 63.3 (1.7) months after CNF. Baseline characteristics were comparable for both groups (Table 1 ). Conversion to an open procedure was required in 6 patients (7.6%). These patients were maintained in the LNF group, also according to the intention to treat principle.
Of the 148 patients, 97 (65.5%) agreed to undergo esophageal manometry and 24-hour pH monitoring (48 LNF, 49 CNF). Informed consent for objective evaluation was given by all participating patients.
Subjective Symptomatic Outcome
Subjective assessment of symptoms, global satisfaction, and quality of life were the 3 principal measures of symptomatic outcome in this study. In Table 2 , the results of subjective outcome are shown with the results of reoperated patients presented separately. No differences in quality of life could be detected for either VAS scores or for symptom assessments. Satisfaction with the outcome of surgery was achieved in 87.3% of patients after LNF and 89.9% after CNF (P ϭ 0.32). A total of 74 patients scored their reflux symptoms as cured or improved after LNF (94.9%) and 61 patients after CNF (88.4%) (P ϭ 0.12). All patients after LNF and all but one after CNF would have chosen surgery again in retrospect. This is consistent with the data in Table 3 showing that failures all opted for reoperation with successful symptomatic outcome in 80% of patients.
Of the 51 patients who refused objective follow-up, 46 (90.2%) were satisfied with the operative results. Five patients with symptoms needed antisecretory drugs on a regular basis.
Esophageal Manometry and 24-Hour pH Monitoring
Results of operation on esophageal manometry are shown in Table 4 . The LES pressure increased significantly, from 1.1 kPa (0.1) to 1.8 (0.1) kPa at 3 to 6 months after LNF (P ϭ 0.001). This effect was sustained at 5 years after surgery with a mean LES pressure of 1.7 (0.2). In the CNF group, preoperative LES pressure was 1.1 (0.1), which increased significantly after surgery (P ϭ 0.000). No significant difference between short-and long-term postoperative results could be detected. Mean distal esophageal amplitudes did not change noticeably in time until 5 years after surgery in both groups.
Total esophageal acid exposure (% of time with pH Ͻ 4) was reduced from 10.5 (1.3) to 2.2 (0.6) after LNF (P ϭ 0.000) and from 11.1 (1.2) to 1.8 (0.6) after CNF (P ϭ 0.000). For both groups, these results were sustained up to 5 years after surgery without significant changes in upright, supine, or total esophageal acid exposure. Five years after surgery, pathologic total acid exposure was found in 6 patients (12.5%) after LNF and in 2 after CNF (4.1%). Of these patients, only 2 had a SAP of more than 95% after LNF and 2 after CNF. Two patients with pathologic total acid exposure, one in each group, were using antisecretory drugs. In Figures 2 and 3 , the durability of the antireflux effect after CNF and LNF is depicted.
Relationship Between Symptoms and Acid Exposure
Surgery not only reduced esophageal acid exposure, but also the number of symptoms during the 24-hour pH-metry and symptom association probability score (SAP) and symptom index (SI) ( Table 5 ). Both the SI and SAP scores were low at 5 years after surgery with 11.9 (4.3) after CNF and 11.0 (4.1) after LNF for the SI (P ϭ 0.85) and 17.2 (5.6) and 17.1 (5.9) for the SAP score, respectively (P ϭ 0.97). Overall, antisecretory agents and/or prokinetics were taken by 11 patients after LNF (13.9%) and by 11 (15.9%) after CNF. Total esophageal acid exposure in these patients was 2.6 (1.5) after LNF and 2.2 (1.1) after CNF (P ϭ 0.23). Also, the mean SAP in these patients did not differ significantly with 39.8 (15.8) after LNF and 34.2 (16.8) after CNF. For both groups no significant correlation could be found between antisecretory drug use and total acid exposure (r s ϭ 0.21 and r s ϭ 0.24) and between daily medication use and symptom indices, SI (r s ϭ 0.10 and r s ϭ 0.22, respectively) and SAP (r s ϭ 0.41 and r s ϭ 0.19), indicating an absence of correlation between the use of PPIs and documented reflux symptoms.
Redo Surgery
All patients scored as failure were reoperated, after dilatation and medical treatment had proven unsuccessful for dysphagia and recurrent GERD, respectively. The indication and details of the procedure are presented in Table 3 . Twenty patients had undergone reoperation in the follow-up period: 12 after LNF (15.1%) and 8 after CNF (11.6%). According to the intention-to-treat principle, these patients were analyzed in their original group. Subjective and objective data for the reoperated patients who participated in the objective follow-up are shown in Tables 2 and 6. Of the 12 patients needing surgical reintervention after LNF, 1 patient required 2 corrections of a cicatricial hernia. Two other patients of these 12 needed a second reintervention for reflux control. Reintervention for persistent dysphagia was needed in 6 patients (6 of 79, 7.8%) after LNF. The majority of patients needing reoperation after LNF were treated 
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Long-term Results of Nissen Fundoplication within 6 months after the primary procedure. In Figure 4 , a life-table analysis of the relation between the duration of follow-up and the probability of needing surgical reintervention for dysphagia or recurrent reflux after both LNF and CNF is depicted. After reoperation, results of esophageal manometry and 24-hour pH-metry were similar to those after primary LNF or CNF ( Table 6 ).
DISCUSSION
In this prospective randomized study with a follow-up up of at least 5 years, we found no difference between the long-term subjective and objective results of laparoscopic and conventional Nissen fundoplication for refractory gastroesophageal reflux disease. This is the follow-up evaluation of the randomized controlled trial that was terminated prematurely and published in 2000. 2 The interim analysis covered the results obtained the results in the initial 103 patients including 3 months of follow-up. About 10 months were needed for full subjective and objective evaluation on this cohort, discussing the results with the monitoring committee and with the national Antireflux Surgery Study Group. Dur-ing this 10-month period, an additional 74 patients were included and most of them operated. When the conclusion to stop the trial was drawn, the remaining patients were informed about this decision and most of them were compliant to their initial randomization. This explains for the 177 patients available for long-term follow-up.
This study is the first to show objective long-term results in a representative percentage of patients. Prior to surgery, all patients were informed that the follow-up time would be at least 5 years to which most of them complied. This underlines that, in a small country like the Netherlands, compliance to follow-up appears to be high.
In the discussion about the medical or surgical treatment of GERD, surgeons have so far not convincingly demonstrated long-term effective reflux control. Open Nissen fundoplication maintains about 90% subjective efficacy in the long term. 12 Several randomized trials comparing LNF with CNF have been published with similar subjective and objective short-term outcome with regard to reflux control and morbidity. 1, 4, [25] [26] [27] Quality of life studies after antireflux surgery, mainly from Scandinavia, have shown lasting satisfac- tion in a subset of the patients operated. 14, 16 Follow-up in these studies, however, often was incomplete and objective data are lacking. This study demonstrates that satisfactory subjective and objective reflux control was obtained in a high proportion of patients. Furthermore, overall patient satisfaction appeared to be high in successful primary cases but low in reoperated patients despite adequate reflux control. Lasting reflux control was attained after both LNF and CNF. Since the majority of the 51 patients who refused participation in objective long-term follow-up evaluation were asymptomatic, these patients are not likely to introduce bias in the results presented taking into account that participation in objective evaluation was requested after collection of the subjective questionnaires.
Other authors have shown long-term success of laparoscopic antireflux surgery, but this was mainly based on quantitative symptom questionnaires. Dassinger et al subjectively concluded that LNF is an effective long-term treatment of GERD, based on the subjective outcome in 52 patients with a mean follow-up of 5.1 years. 28 Kamolz et al found in 169 patients that both Nissen and Toupet laparoscopic fundoplication significantly improved patients' quality of life during 5 years after surgery. 9 Scores for both groups were almost equal and patient satisfaction with surgical treatment was high (97.9%). Alternatively, it has been suggested that patients after LNF have a slowly increasing need for antisecretory drugs, suggesting a slow increase in failure rate. 17, 20 In this study, we have demonstrated that the effects of LNF and CNF on symptoms and general state of health are similar, that they do not change with time, and that they are sustained up to 5 years after surgery.
The absence of a correlation between daily use of antisecretory drugs and esophageal acid exposure in patients taking PPIs or H 2 -receptor antagonists observed in the present study underlines the difficulty to adequately interpret the patient's symptoms as induced by reflux. Symptoms, perceived as recurrent or persisting reflux during pH-metry at 5 years, were not correlated to an acid reflux episode and it could not be clarified whether these symptoms apparently needing medical treatment were present already before surgery or whether they should be ascribed to alterations in gastroesophageal physiology as a result of fundoplication. 29 -31 These data are in support of earlier reports showing absence of a relationship between reflux-related symptoms and esophageal acid exposure after both medical and surgical treatment of GERD. 19 In a recent study by Jenkinson et al, it was demonstrated that the symptomatic response to treatment of GERD is a poor denominator in evaluating the efficacy of treatment, if objective normalization of esophageal acid exposure is the aim of treatment. 32 They conclude that a high proportion of patients whose symptoms are improved by PPIs still have pathologic levels of acid reflux and, conversely, most patients who complain of reflux symptoms after antireflux surgery have no evidence of persistently excessive reflux on 24-hour pH-metry. Recurrent reflux has been reported in 7% to 10% and dysphagia in 6% to 14% after Nissen fundoplication. 33 The reported rate of reoperation after laparoscopic antireflux surgery varies from 2% to 10%. 34, 35 In this series, the reoperation rate is high, with 13.5% of patients needing surgical reintervention for recurrent symptoms. The majority of these reoperations were needed in the first 2 years after surgery and in the LNF group most of these were needed for troublesome dysphagia. This could not be ascribed to differences in surgical technique as in this trial the surgical procedure was standardized and prescribed division of the short gastric vessels in each patient. In retrospect, the high percentage of dysphagia is most likely due to the fact that the learning curve turned out to be longer than initially calculated. 36 -38 The exact length of the learning curve in LNF, which is hard to define due to the diversity of outcome measures reported in the literature, amounts to 30 procedures based on failure and reoperation rates comparable with those obtained after CNF. 38 In our opinion, this is almost inevitable in a pragmatic surgical trial, if one starts too early, the learning curve may not have been completed yet and if one chooses to await the completion of the learning curve, a randomized trial is no longer needed. In other words, we do not regret to have stopped the trial because the arguments were undeniable and continuation would have been unethical. With this 5 year follow-up evaluation, however, we come very close to the information we would have been able to collect if 200 patients would have been randomized and treated. 
